Goa Medical Research Profile
Key Indicators
- Authorised Capital ₹ 30.00 Cr
as on 04-05-2024
- Paid Up Capital ₹ 20.83 Cr
as on 04-05-2024
- Company Age 23 Year, 2 Months
- Last Filing with ROC 31 Mar 2021
- Revenue 6.18%
(FY 2017)
- Profit 69.64%
(FY 2017)
- Ebitda -19.47%
(FY 2017)
- Net Worth -2.53%
(FY 2017)
- Total Assets -2.07%
(FY 2017)
About Goa Medical Research
- CIN/LLPIN
U73100GA2001PTC004065
- Company No.
004065
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Oct 2001
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Goa
Industry
Company Details
- Location
North Goa, Goa, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Goa Medical Research?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Balasubramanian Ganapathy  | Company Secretary | 01-Apr-2019 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shrinivas Dempo | Director | 03-Jun-2019 | Current |
| Yatish Dempo | Director | 03-Jun-2019 | Current |
| Sharmila Prabhu | Director | 01-Apr-2019 | Current |
| Krishna Mantri | Director | 07-May-2018 | Current |
Financial Performance and Corporate Structure Insights of Goa Medical Research.
Goa Medical Research Private Limited, for the financial year ended 2017, experienced modest growth in revenue, with a 6.18% increase. The company also saw a substantial improvement in profitability, with a 69.64% increase in profit. The company's net worth dipped by a decrease of 2.53%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Goa Medical Research?
In 2017, Goa Medical Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Dempo Sports Club Private LimitedActive 16 years 5 monthsShrinivas Dempo and Sharmila Prabhu are mutual person
Devashri Nirman Limited Liability Partne RshipActive 13 years 3 monthsShrinivas Dempo is a mutual person
- V.S.Dempo Mining Corporation Private LimitedActive 26 years 7 months
Shrinivas Dempo is a mutual person
- V.S.Dempo Holdings Private LimitedActive 40 years 8 months
Shrinivas Dempo and Yatish Dempo are mutual person
- Dempo Shipbuilding And Engineering Private LimitedActive 61 years 1 month
Shrinivas Dempo, Yatish Dempo and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Goa Medical Research?
Unlock and access historical data on people associated with Goa Medical Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Goa Medical Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Goa Medical Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
